207 related articles for article (PubMed ID: 32679166)
21. Perp is a mediator of p53-dependent apoptosis in diverse cell types.
Ihrie RA; Reczek E; Horner JS; Khachatrian L; Sage J; Jacks T; Attardi LD
Curr Biol; 2003 Nov; 13(22):1985-90. PubMed ID: 14614825
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to cancer treatment using structural hybrids of the p53 gene family.
Sasaki Y; Oshima Y; Koyama R; Tamura M; Kashima L; Idogawa M; Yamashita T; Toyota M; Imai K; Shinomura Y; Tokino T
Cancer Gene Ther; 2012 Nov; 19(11):749-56. PubMed ID: 22956039
[TBL] [Abstract][Full Text] [Related]
23. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
Jafarnejad SM; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
[TBL] [Abstract][Full Text] [Related]
24. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
25. Mice lacking the p53/p63 target gene Perp are resistant to papilloma development.
Marques MR; Horner JS; Ihrie RA; Bronson RT; Attardi LD
Cancer Res; 2005 Aug; 65(15):6551-6. PubMed ID: 16061634
[TBL] [Abstract][Full Text] [Related]
26. PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF.
Chen K; Luo Z; Li Z; Liu Y; Zhao Q
Cancer Biol Ther; 2011 Dec; 12(12):1114-9. PubMed ID: 22236877
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.
Koyama R; Tamura M; Nakagaki T; Ohashi T; Idogawa M; Suzuki H; Tokino T; Sasaki Y
Cancer Sci; 2017 Dec; 108(12):2413-2421. PubMed ID: 29030916
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
[TBL] [Abstract][Full Text] [Related]
29. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome.
Neilsen PM; Noll JE; Suetani RJ; Schulz RB; Al-Ejeh F; Evdokiou A; Lane DP; Callen DF
Oncotarget; 2011 Dec; 2(12):1203-17. PubMed ID: 22203497
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.
Sasaki Y; Tamura M; Takeda K; Ogi K; Nakagaki T; Koyama R; Idogawa M; Hiratsuka H; Tokino T
Oncotarget; 2016 Sep; 7(38):61426-61437. PubMed ID: 27556181
[TBL] [Abstract][Full Text] [Related]
31. The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes.
Kirschner RD; Rother K; Müller GA; Engeland K
Cell Cycle; 2010 Jun; 9(11):2177-88. PubMed ID: 20543567
[TBL] [Abstract][Full Text] [Related]
32. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway.
Ye S; Lee KB; Park MH; Lee JS; Kim SM
Int J Oncol; 2014 Jun; 44(6):2153-9. PubMed ID: 24718831
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
Chow SE; Wang JS; Chuang SF; Chang YL; Chu WK; Chen WS; Chen YW
Cancer Gene Ther; 2010 Dec; 17(12):872-82. PubMed ID: 20725098
[TBL] [Abstract][Full Text] [Related]
34.
Qian YC; Xie YX; Wang CS; Shi ZM; Jiang CF; Tang YY; Qian X; Wang L; Jiang BH
Asian J Androl; 2020; 22(4):414-421. PubMed ID: 31489847
[TBL] [Abstract][Full Text] [Related]
35. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
36. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
37. Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors.
Kiseljak-Vassiliades K; Mills TS; Zhang Y; Xu M; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
Endocrinology; 2017 May; 158(5):1450-1460. PubMed ID: 28323918
[TBL] [Abstract][Full Text] [Related]
38. The p53 effector Perp mediates the persistence of CD4
Zhou Y; Leng X; Mo C; Zou Q; Liu Y; Wang Y
Immunol Lett; 2020 Aug; 224():14-20. PubMed ID: 32473185
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic Viral Protein Interactions with p53 Family Proteins.
Brychtová V; Hrabal V; Vojtěšek B
Klin Onkol; 2019; 32(Supplementum 3):72-77. PubMed ID: 31627709
[TBL] [Abstract][Full Text] [Related]
40. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
Shan BQ; Wang XM; Zheng L; Han Y; Gao J; Lv MD; Zhang Y; Liu YX; Zhang H; Chen HS; Ao L; Zhang YL; Lu X; Wu ZJ; Xu Y; Che X; Heger M; Cheng SQ; Pan WW; Zhang X
Cancer Sci; 2022 May; 113(5):1587-1600. PubMed ID: 35178836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
